Bpifrance Innovation Grants and Loans: Feasibility, R&D, Deeptech, and Startup Funding Routes

France offers one of Europe’s most developed public innovation finance systems, but the system is often misunderstood. Companies frequently search for a single “Bpifrance innovation grant” that could finance everything from an early feasibility study to product development, industrial production, and commercial expansion.

That is not how Bpifrance funding works.

Bpifrance uses different instruments for different stages of the innovation cycle. A young company testing whether an idea is technically and commercially viable may need a feasibility grant. A small or medium-sized enterprise conducting experimental development may require a recoverable advance or an R&D loan. A deeptech startup may follow a dedicated route that reflects longer development cycles and higher technological risk. Once the innovation is ready for the market, a company may need a loan for industrialisation, working capital, or commercial launch rather than another R&D subsidy.

The practical question is therefore not simply, “Which Bpifrance grant can we obtain?” It is:

What is the current stage of the project, what uncertainty remains, which costs must be financed, and can the company eventually repay part of the support?

This article explains how the main Bpifrance innovation instruments fit together, how feasibility, R&D, deeptech, seed, and market-launch funding differ, and how French startups and SMEs can select the most appropriate route.

This article reflects publicly available programme information as of July 2026. Financial terms, eligibility rules, regional availability, and application procedures should always be confirmed with Bpifrance before costs are committed.

Bpifrance Does Not Finance Every Innovation in the Same Way

Bpifrance supports innovation through grants, recoverable advances, loans, equity instruments, guarantees, advisory services, and programmes managed on behalf of the French state. Its offer covers much of the company development cycle, from the first validation of an innovative concept to industrialisation and commercial growth.

However, these instruments are not interchangeable.

A grant is generally better suited to a project that still contains substantial technical, market, or organisational uncertainty. A recoverable advance can finance a more structured R&D programme while sharing some of the project risk. A loan is more appropriate when the company has sufficient financial capacity and a credible route to future revenue or investment.

Bpifrance also distinguishes between ordinary technological innovation and deeptech. Deeptech projects are based on major scientific or technological advances, often originating in research laboratories. They generally require longer development periods, larger capital commitments, and more complex intellectual property, regulatory, and industrial strategies. The French government’s updated Deeptech Plan describes these projects as innovations built on major scientific or technological breakthroughs, often following years of fundamental and applied research.

Table 1. Main Bpifrance Innovation Funding Routes by Project Stage

Funding route	Typical project stage	Main purpose	Form of support	Indicative maximum or range
Bourse French Tech	Concept maturation and early feasibility	Validate the technical, commercial, legal, financial, or organisational foundations of an innovative project	Grant	Up to €30,000
Subvention Innovation	Feasibility and preparation of an R&D programme	Finance internal and external studies required before a larger development project	Grant	Up to €50,000
Bourse French Tech Emergence	Early deeptech maturation	Evaluate the potential and feasibility of a breakthrough technology project	Grant	Up to €90,000
Avance Innovation Classique	Structured research and experimental development	Finance an innovation project before industrial or commercial launch	Recoverable advance	Up to €3 million
Prêt Innovation R&D Classique	Research, experimental development, process innovation, or organisational innovation	Finance an R&D programme before production or commercial launch	Loan	Up to €3 million
Aide au Développement Deeptech	Breakthrough R&D with significant technological risk	Develop a deeptech solution before industrial or commercial launch	Combination of grant and recoverable advance	Up to €2 million
Prêt Amorçage	Preparation for an initial equity round	Strengthen cash flow while the company prepares fundraising	Unsecured loan	Depends on the applicable product variant
Prêt Innovation Relance InvestEU	Industrial and commercial launch	Finance intangible costs and working capital associated with bringing an innovation to market	Unsecured loan	€50,000 to €2 million
France 2030 innovation competitions	Research commercialisation, startup creation, or high-potential R&D	Support selected projects through i-PhD, i-Lab, i-Nov, and other calls	Grant or mixed public support	Depends on the competition

The current Bpifrance catalogue sets maximum support at €30,000 for Bourse French Tech, €50,000 for Subvention Innovation, €90,000 for Bourse French Tech Emergence, €3 million for Avance Innovation Classique, €3 million for Prêt Innovation R&D Classique, and €2 million for Aide au Développement Deeptech. Funding intensity, final award size, and the balance between grant and repayable support depend on the company, project, eligible costs, state aid rules, and Bpifrance assessment.

Feasibility Funding: Bourse French Tech and Subvention Innovation

Many innovation projects should not begin with a full R&D programme. Before committing significant resources, the company may need to establish whether the proposed solution can work, whether customers will pay for it, whether intellectual property can be protected, and whether the business has the skills and financing needed to complete development.

This is the role of feasibility funding.

Bourse French Tech

Bourse French Tech supports innovative projects during the maturation and feasibility phase. It is particularly relevant to recently created companies and early-stage ventures that must turn an initial concept into a credible development plan.

The grant can reach €30,000. Bpifrance materials indicate that the support may cover up to 70 percent of accepted forecast expenditure, subject to assessment and applicable aid rules.

The instrument can help a company examine several dimensions of feasibility, including technical design, commercial positioning, legal constraints, intellectual property, financial modelling, and management capacity. It is not intended to finance an entire product development and market-entry programme.

A strong Bourse French Tech application should therefore identify the questions that must be answered before the company can responsibly proceed. The proposed work should produce evidence, decisions, or validated assumptions rather than simply fund routine startup operating costs.

Subvention Innovation

Subvention Innovation serves a similar preparation function but can support a broader or more advanced feasibility programme. The current product has a maximum grant of €50,000. Bpifrance describes it as partial financing for internal and external R&D expenditure connected with an innovation project.

The instrument may be appropriate when an established SME needs to determine whether a planned innovation is technically realistic, commercially relevant, legally manageable, and financially sustainable before launching a larger R&D programme.

The distinction between Bourse French Tech and Subvention Innovation is not based solely on the amount requested. The company’s age, maturity, regional context, project content, and planned development route all matter. Applicants should discuss the intended project with the relevant Bpifrance regional team rather than assuming that the higher maximum automatically makes Subvention Innovation the better option.

What Feasibility Funding Should Produce

A feasibility project should end with a clearer investment decision. Depending on the technology and market, its outputs may include:

• a technical feasibility report, laboratory result, preliminary design, or proof of concept;

• a market study supported by customer interviews, demand analysis, and competitor mapping;

• an intellectual property review, freedom-to-operate analysis, or licensing strategy;

• a regulatory, certification, cybersecurity, or data protection assessment;

• a detailed R&D work plan, project budget, risk register, and financing strategy;

• a decision to proceed, redesign, postpone, partner, license, or discontinue the project.

These outputs become the foundation of a later application for an R&D grant, recoverable advance, loan, France 2030 competition, equity investment, or collaborative European programme.

Financing R&D: Recoverable Advances and Innovation Loans

Once feasibility has been established, the company may enter industrial research or experimental development. At this stage, engineers and researchers are no longer only assessing whether the project should proceed. They are developing, integrating, testing, and validating the actual solution.

Bpifrance offers two important routes for this stage: the recoverable advance and the R&D innovation loan.

Avance Innovation Classique

Avance Innovation Classique is a recoverable advance for innovation projects conducted before industrial or commercial launch. The support can reach €3 million, and the programme duration can be up to 36 months.

A recoverable advance occupies a middle position between a grant and a conventional loan. It provides funding for a risky development programme, but the company may be required to repay the support under the terms of the agreement. The repayment structure is linked to the contractual conditions established for the project.

This route can be attractive when the project contains meaningful development risk but has progressed beyond preliminary feasibility. It can also reduce immediate pressure on company liquidity while maintaining public scrutiny over the development milestones and use of funds.

Applicants must nevertheless understand that a recoverable advance is not free capital. The financial plan should reflect future repayment obligations, and the company must demonstrate sufficient resources to complete the programme.

Prêt Innovation R&D Classique

Prêt Innovation R&D Classique finances technological innovation before industrial or commercial launch. It can cover industrial research, experimental development, process innovation, organisational innovation, and feasibility studies.

The product is available to companies registered in France that qualify as SMEs under the European definition, as well as mid-cap companies with up to 2,000 employees. The loan can reach €3 million, subject to a limit of twice the borrower’s equity and quasi-equity. Its term is between five and eight years, including a principal repayment deferral of 12 to 36 months.

The equity limit is particularly important. A technically excellent startup with weak capitalisation may not be able to borrow the amount required for its entire R&D programme. Public debt cannot fully replace shareholder capital.

Prêt Innovation R&D is therefore usually more suitable for a company that has already demonstrated organisational and financial capacity, has a credible budget, and can show how the project will lead to future economic value.

R&D Is Not the Same as Industrial or Commercial Launch

One of the most common application errors is placing all innovation-related expenditure into a single R&D budget.

Bpifrance explicitly excludes from Prêt Innovation R&D:

• expenditure committed before the aid application was submitted;

• industrial launch costs;

• production expenditure;

• commercialisation expenditure.

The instrument finances the work required to develop and validate the innovation before it enters industrial production or the market. It does not finance routine manufacturing, stock accumulation, sales operations, or a full commercial rollout.

This distinction should influence how the company structures both its budget and its financing strategy.

A project may require one financing package for feasibility, a second for R&D, and a third for industrialisation or market entry. Trying to place every cost under an R&D instrument can weaken the application and make the budget appear poorly understood.

The Dedicated Deeptech Route

Deeptech projects face a specific combination of scientific, technological, financial, and industrial risk. They often emerge from universities, public research organisations, engineering schools, hospitals, or specialised corporate research.

A deeptech company must generally address questions that ordinary digital or service startups may not face at the same intensity. These include ownership of research results, licences from public laboratories, freedom to operate, access to specialised equipment, scientific recruitment, regulation, certification, pilot manufacturing, and long timeframes before revenue.

Bpifrance has therefore developed dedicated deeptech instruments.

Bourse French Tech Emergence

Bourse French Tech Emergence supports the early emergence of deeptech projects. It is aimed at startups that are generally less than one year old and can provide a grant of up to €90,000. Bpifrance states that support may cover up to 70 percent of accepted expenditure.

The grant is intended to help evaluate and analyse the project’s innovation potential and market prospects. It may support technological maturation, scientific validation, market analysis, intellectual property work, regulatory preparation, or other studies required before a larger development programme.

A company should not describe itself as deeptech merely because its product uses artificial intelligence, advanced software, biotechnology, or complex engineering. The application must demonstrate a substantial scientific or technological barrier, a genuine research foundation, and a development path that would be difficult for competitors to reproduce quickly.

Aide au Développement Deeptech

Aide au Développement Deeptech finances breakthrough R&D through a combination of grant and recoverable advance. It is available to French SMEs and mid-cap companies with up to 2,000 employees.

The support can reach €2 million for a programme lasting up to 36 months. It must concern industrial research or experimental development conducted before industrial or commercial launch. Expenditure committed before submission of the application is not eligible.

This instrument is relevant when the project has moved beyond initial maturation and the company must solve major technological challenges, build and test prototypes, complete experimental development, or prepare the innovation for later industrialisation.

The application must do more than present an ambitious scientific vision. It should connect the scientific programme to a defensible intellectual property position, a real market need, a credible industrial route, and a financing plan capable of supporting the company after the public aid period ends.

France’s Deeptech Ecosystem Is Moving Toward Scale-Up

France’s deeptech ecosystem has expanded considerably since the launch of the national Deeptech Plan in 2019. According to Bpifrance, the number of deeptech startups created annually increased from 207 in 2019 to 410 in 2025.

In 2025, French deeptech companies raised €4.1 billion, representing approximately half of all French Tech fundraising. Bpifrance counted 2,830 active deeptech startups generating €5.4 billion in revenue and supporting 50,000 direct jobs. These companies operated more than 200 industrial sites and included 15 unicorns and nearly 60 listed startups.

The updated national Deeptech Plan, presented in 2026, places greater emphasis on growth, industrialisation, and later-stage financing. By 2030, France aims to reduce technology-transfer negotiations to no more than six months, mobilise at least €30 billion in public and private financing between 2025 and 2030, generate more than €15 billion in ecosystem revenue, and create 100,000 direct deeptech jobs.

For applicants, this policy shift means that a deeptech project should not stop at laboratory validation. Bpifrance and France 2030 increasingly expect companies to explain how the innovation can become an industrially and commercially viable business.

Seed Loans and Equity-Round Preparation

Grants and R&D support do not eliminate the need for private capital. Innovative companies often face a gap between completing technical work and closing an equity round.

Bpifrance’s seed loan products are intended to reinforce company cash flow while a fundraising operation is being prepared. The current Prêt Amorçage InvestEU product has a term of eight years, including a three-year principal repayment deferral. Precise amounts and conditions depend on the relevant product and company assessment.

A seed loan may provide additional time to complete technical milestones, strengthen the management team, secure initial commercial evidence, finalise intellectual property arrangements, or prepare investor due diligence.

However, it should not be treated as a substitute for a realistic fundraising plan. The company must show how the loan will improve its ability to raise equity and how the future capital round will support both growth and debt repayment.

Financing Industrial and Commercial Launch

When the technical development programme has been completed, the company may need to fund industrial preparation, market entry, recruitment, marketing, certification, software deployment, distribution, working capital, or other intangible expenditure.

This is where market-launch instruments become more relevant.

Prêt Innovation Relance InvestEU is designed for companies launching an innovative product, process, or service. The current product ranges from €50,000 to €2 million and has a seven-year term, including two years of deferred principal repayment.

Bpifrance describes innovation loans as financing the intangible expenditure needed for industrialisation and commercialisation. This creates a clear dividing line:

Prêt Innovation R&D finances development before launch. Prêt Innovation finances the costs of turning a completed innovation into a market-ready and scalable business.

For an industrial startup, additional instruments such as Prêt Nouvelle Industrie or France 2030 industrial calls may be necessary when the project includes a pilot line, demonstrator, first factory, or larger production investment.

France 2030 Competitions Operated by Bpifrance

Not every innovation programme available through Bpifrance is a standard catalogue product. Bpifrance also operates competitive calls financed by the French state, particularly under France 2030.

France 2030 has an overall budget of €54 billion. It combines €10 billion of structural support, which allows projects to emerge from companies and research organisations, with €44 billion of directed support for strategic sectors selected by the state.

The France 2030 innovation competitions include i-PhD, i-Lab, and i-Nov.

i-PhD helps young researchers explore the entrepreneurial potential of research-based projects. i-Lab supports the creation and early development of innovative technology companies, with funding of up to €600,000 per project. i-Nov supports high-potential R&D projects led by startups and SMEs.

For the 2024 to 2025 competition cycle, 147 winners received a combined €74 million in support. This included 40 i-PhD projects, 62 i-Lab winners, and 45 i-Nov winners. The i-Lab winners received €23 million in total, while the i-Nov projects received more than €51 million. The supported i-Nov projects had total project costs between €1 million and €5 million.

These competitions should not be treated as permanently open grants. Themes, budgets, deadlines, project cost thresholds, and selection criteria change between calls. A company must assess the current competition documentation rather than relying on the conditions of an earlier wave.

Table 2. Typical Eligible and Ineligible Innovation Costs

Cost category	Feasibility grant	R&D support	Industrial or commercial launch finance
Technical feasibility studies	Usually relevant	May be relevant if part of the R&D programme	Normally not the main purpose
Internal R&D personnel	Limited or targeted	Core eligible category	Usually not eligible as R&D, but certain implementation staff costs may fit the launch instrument
External laboratories and engineering services	Often eligible	Commonly eligible	Only where directly connected to launch or industrial preparation
Prototype and demonstrator development	Preliminary prototype may be eligible	Core eligible category	Commercial production units require another route
Intellectual property studies and protection	Often eligible	Commonly eligible	May be relevant for market deployment
Market and customer validation	Often eligible	May be eligible when connected to the innovation project	Commercial deployment costs may fit a launch loan
Production equipment	Generally not appropriate	Depreciation or project use may be considered in some cases	May require an industrial loan, leasing, or France 2030 call
Routine production	Not eligible	Not eligible under Prêt Innovation R&D	Requires production or working-capital finance
Sales campaigns and ordinary advertising	Not the main purpose	Not eligible as R&D	May be considered only under an appropriate commercial-launch instrument
Costs incurred before the application	High eligibility risk	Explicitly excluded under several instruments	Depends on the specific product, but prior commitment remains a major risk

The exact eligibility of every cost must be confirmed against the applicable product rules and the written funding agreement. Applicants should never assume that a cost is eligible merely because it is associated with an innovative company.

How Bpifrance Evaluates an Innovation Project

Bpifrance assessment is broader than a technical review. A project can be scientifically impressive and still fail to secure support if the company cannot demonstrate economic relevance, execution capacity, or financial sustainability.

The evaluation usually considers the project’s degree of innovation, the technical barriers to be addressed, the quality of the development programme, the skills of the team, the market opportunity, competitive positioning, intellectual property, the financial plan, and the route to industrial or commercial impact.

The company should be able to explain what is genuinely uncertain at the start of the project and what evidence will demonstrate successful completion. A vague promise to “develop an innovative platform” is weaker than a programme with defined technical milestones, test conditions, performance targets, decision points, and measurable deliverables.

The market case is equally important. Public support is intended to help economically useful projects that may not proceed at the same scale or speed without aid. French innovation support also remains subject to European Union state aid rules.

Table 3. Which Bpifrance Instrument Fits Your Project?

Project situation	Most relevant starting route	Why it may fit	Main warning
A newly created startup must test whether an innovative concept is viable	Bourse French Tech	Supports early maturation and feasibility	Do not include a complete multi-year development programme
An SME needs technical, legal, market, and financial studies before launching R&D	Subvention Innovation	Prepares a structured innovation programme	The outputs must support a real investment decision
A young research-based startup must validate a breakthrough technology	Bourse French Tech Emergence	Designed for early deeptech maturation	The project must demonstrate a genuine scientific or technological barrier
An SME has a defined R&D programme but substantial development risk remains	Avance Innovation Classique	Shares development risk through recoverable support	Future repayment obligations must be included in financial forecasts
A capitalised SME needs up to several million euros for pre-launch R&D	Prêt Innovation R&D Classique	Provides longer-term debt for research and experimental development	The loan is capped by equity and excludes production and commercialisation
A deeptech company must complete breakthrough R&D before industrial launch	Aide au Développement Deeptech	Combines grant and recoverable advance	Costs committed before submission are excluded
An innovative company is preparing its first equity round	Prêt Amorçage	Reinforces cash flow before fundraising	It must support, not replace, a credible equity strategy
A company has completed R&D and must launch the innovation commercially	Prêt Innovation Relance InvestEU	Finances intangible launch and commercialisation expenditure	The company must demonstrate repayment capacity
A high-potential project matches an active strategic competition	i-Lab, i-Nov, or another France 2030 call	Can provide larger project-based public support	Competition is selective and conditions change by wave

What Changed in 2025 and 2026

Bpifrance’s 2025 activity shows a shift toward financing more mature innovation projects.

In 2025, Bpifrance deployed €3.4 billion in innovation financing to almost 4,900 companies. Structural innovation aid reached €1.16 billion and supported nearly 4,000 companies. This total included €270 million distributed through national calls and almost €890 million deployed through the Bpifrance regional network. Regionalised France 2030 support reached €157 million.

At the same time, unsecured innovation loans increased by 43 percent to €575 million. Prêt Innovation financing for industrial and commercial launch reached €198 million, three times the 2024 level. Prêt Nouvelle Industrie reached €135 million, an increase of 136 percent.

These figures indicate that French innovation policy is increasingly concerned with what happens after the technical project succeeds. Creating prototypes remains important, but companies must also be able to industrialise, enter markets, and scale.

This does not mean early-stage grants are disappearing. It means that applicants should present a complete financing pathway. A credible proposal should explain not only how the current R&D phase will be funded, but also what financing will be required for certification, industrialisation, market entry, working capital, and growth.

Building a Strong Bpifrance Application

A well-prepared company should complete the following steps before formally submitting an innovation funding request:

1. Define the project stage. Separate concept validation, feasibility, research, experimental development, industrialisation, and commercial launch.

2. Identify the real uncertainty. Explain which scientific, technical, commercial, legal, or organisational questions remain unresolved.

3. Separate the budgets. Do not mix R&D expenditure with routine production, ordinary sales costs, or unrelated company overhead.

4. Check the project start date. Avoid signing binding contracts, ordering major work, or committing project expenditure before confirming the applicable incentive-effect rules.

5. Demonstrate financing capacity. Show available equity, expected cash flow, private investment, bank finance, and other public support.

6. Describe the route after the funded phase. Explain how the project will progress toward regulatory approval, production, customers, revenue, fundraising, or international expansion.

The application should also clearly identify related companies, previous public aid, research partners, subcontractors, intellectual property ownership, and any planned combination with tax credits such as the Crédit d’Impôt Recherche or Crédit d’Impôt Innovation.

Common Mistakes to Avoid

• Applying for the largest available instrument rather than the instrument that matches the actual project stage.

• Presenting routine business development as technical innovation.

• Calling a project deeptech without demonstrating a major scientific or technological barrier.

• Starting funded work before the application date.

• Combining research, production, marketing, and working-capital costs in one undifferentiated budget.

• Requesting debt without sufficient equity, liquidity, or a realistic repayment strategy.

• Describing the technology in detail while providing weak evidence of customer demand, competition, or commercial potential.

• Assuming that Bpifrance support will finance 100 percent of the project.

The Best Funding Route Is Usually a Sequence, Not a Single Product

The strongest innovation financing strategies often combine several instruments over time.

A startup might begin with Bourse French Tech to validate feasibility, use a recoverable advance or R&D loan to complete development, obtain a seed loan while preparing an equity round, and later use Prêt Innovation to finance commercial launch.

A deeptech company might start with Bourse French Tech Emergence, progress to Aide au Développement Deeptech, compete for i-Lab or i-Nov support, raise private capital, and then use industrial financing for a pilot line or first factory.

An established SME might use Subvention Innovation to prepare a development programme, finance the R&D phase through Prêt Innovation R&D, claim eligible research tax credits, and use a separate market-launch or industrial loan after technical validation.

Each stage requires a new assessment of risk, eligible costs, financing capacity, and expected results.

Conclusion

Bpifrance provides a broad innovation funding system, but success depends on selecting the right instrument at the right moment.

Feasibility grants are designed to answer the questions that must be resolved before major investment. Recoverable advances and R&D loans support structured development before industrial or commercial launch. Dedicated deeptech instruments address projects with major scientific and technological barriers. Seed loans prepare innovative companies for equity fundraising, while innovation loans help move completed solutions into production and the market.

The most important preparation step is therefore not completing an application form. It is dividing the company’s innovation journey into financially and technically coherent stages.

For most applicants, the correct decision process is:

Project stage → remaining uncertainty → eligible costs → company profile → equity and repayment capacity → appropriate Bpifrance instrument → next financing stage

A company that can explain this sequence clearly is more likely to present a credible project, avoid ineligible expenditure, and build a financing structure that supports innovation from the first feasibility study to commercial scale.